BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

674 related articles for article (PubMed ID: 23629718)

  • 1. Molecular mechanisms of drug resistance in clinical Candida species isolated from Tunisian hospitals.
    Eddouzi J; Parker JE; Vale-Silva LA; Coste A; Ischer F; Kelly S; Manai M; Sanglard D
    Antimicrob Agents Chemother; 2013 Jul; 57(7):3182-93. PubMed ID: 23629718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activity of Isavuconazole and Other Azoles against Candida Clinical Isolates and Yeast Model Systems with Known Azole Resistance Mechanisms.
    Sanglard D; Coste AT
    Antimicrob Agents Chemother; 2016 Jan; 60(1):229-38. PubMed ID: 26482310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Facultative sterol uptake in an ergosterol-deficient clinical isolate of Candida glabrata harboring a missense mutation in ERG11 and exhibiting cross-resistance to azoles and amphotericin B.
    Hull CM; Parker JE; Bader O; Weig M; Gross U; Warrilow AG; Kelly DE; Kelly SL
    Antimicrob Agents Chemother; 2012 Aug; 56(8):4223-32. PubMed ID: 22615281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of global antifungal surveillance results reveals predominance of Erg11 Y132F alteration among azole-resistant Candida parapsilosis and Candida tropicalis and country-specific isolate dissemination.
    Castanheira M; Deshpande LM; Messer SA; Rhomberg PR; Pfaller MA
    Int J Antimicrob Agents; 2020 Jan; 55(1):105799. PubMed ID: 31520783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and characterization of four azole-resistant erg3 mutants of Candida albicans.
    Martel CM; Parker JE; Bader O; Weig M; Gross U; Warrilow AG; Rolley N; Kelly DE; Kelly SL
    Antimicrob Agents Chemother; 2010 Nov; 54(11):4527-33. PubMed ID: 20733039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MDR1 overexpression combined with ERG11 mutations induce high-level fluconazole resistance in Candida tropicalis clinical isolates.
    Jin L; Cao Z; Wang Q; Wang Y; Wang X; Chen H; Wang H
    BMC Infect Dis; 2018 Apr; 18(1):162. PubMed ID: 29631565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A clinical isolate of Candida albicans with mutations in ERG11 (encoding sterol 14alpha-demethylase) and ERG5 (encoding C22 desaturase) is cross resistant to azoles and amphotericin B.
    Martel CM; Parker JE; Bader O; Weig M; Gross U; Warrilow AG; Kelly DE; Kelly SL
    Antimicrob Agents Chemother; 2010 Sep; 54(9):3578-83. PubMed ID: 20547793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. UPC2A is required for high-level azole antifungal resistance in Candida glabrata.
    Whaley SG; Caudle KE; Vermitsky JP; Chadwick SG; Toner G; Barker KS; Gygax SE; Rogers PD
    Antimicrob Agents Chemother; 2014 Aug; 58(8):4543-54. PubMed ID: 24867980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two clinical isolates of Candida glabrata exhibiting reduced sensitivity to amphotericin B both harbor mutations in ERG2.
    Hull CM; Bader O; Parker JE; Weig M; Gross U; Warrilow AG; Kelly DE; Kelly SL
    Antimicrob Agents Chemother; 2012 Dec; 56(12):6417-21. PubMed ID: 23027188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monitoring Antifungal Resistance in a Global Collection of Invasive Yeasts and Molds: Application of CLSI Epidemiological Cutoff Values and Whole-Genome Sequencing Analysis for Detection of Azole Resistance in Candida albicans.
    Castanheira M; Deshpande LM; Davis AP; Rhomberg PR; Pfaller MA
    Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28784671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Candida albicans mutations in the ergosterol biosynthetic pathway and resistance to several antifungal agents.
    Sanglard D; Ischer F; Parkinson T; Falconer D; Bille J
    Antimicrob Agents Chemother; 2003 Aug; 47(8):2404-12. PubMed ID: 12878497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterologous Expression of Full-Length Lanosterol 14α-Demethylases of Prominent Fungal Pathogens Candida albicans and Candida glabrata Provides Tools for Antifungal Discovery.
    Keniya MV; Ruma YN; Tyndall JDA; Monk BC
    Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30126959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resistance Mechanisms and Clinical Features of Fluconazole-Nonsusceptible Candida tropicalis Isolates Compared with Fluconazole-Less-Susceptible Isolates.
    Choi MJ; Won EJ; Shin JH; Kim SH; Lee WG; Kim MN; Lee K; Shin MG; Suh SP; Ryang DW; Im YJ
    Antimicrob Agents Chemother; 2016 Jun; 60(6):3653-61. PubMed ID: 27044550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Azole resistance in Candida spp].
    Kakeya H; Miyazaki T; Miyazaki Y; Kohno S
    Nihon Ishinkin Gakkai Zasshi; 2003; 44(2):87-92. PubMed ID: 12748589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gain-of-function mutations in UPC2 are a frequent cause of ERG11 upregulation in azole-resistant clinical isolates of Candida albicans.
    Flowers SA; Barker KS; Berkow EL; Toner G; Chadwick SG; Gygax SE; Morschhäuser J; Rogers PD
    Eukaryot Cell; 2012 Oct; 11(10):1289-99. PubMed ID: 22923048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upc2-mediated mechanisms of azole resistance in
    Li J; Aubry L; Brandalise D; Coste AT; Sanglard D; Lamoth F
    Microbiol Spectr; 2024 Feb; 12(2):e0352623. PubMed ID: 38206035
    [No Abstract]   [Full Text] [Related]  

  • 17. Assessment of antifungal resistance and associated molecular mechanism in Candida albicans isolates from different cohorts of patients in North Indian state of Haryana.
    Kumar A; Nair R; Kumar M; Banerjee A; Chakrabarti A; Rudramurthy SM; Bagga R; Gaur NA; Mondal AK; Prasad R
    Folia Microbiol (Praha); 2020 Aug; 65(4):747-754. PubMed ID: 32219719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations and/or Overexpressions of ERG4 and ERG11 Genes in Clinical Azoles-Resistant Isolates of Candida albicans.
    Feng W; Yang J; Xi Z; Qiao Z; Lv Y; Wang Y; Ma Y; Wang Y; Cen W
    Microb Drug Resist; 2017 Jul; 23(5):563-570. PubMed ID: 27976986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss-of-Function
    Ollinger TL; Vu B; Murante D; Parker JE; Simonicova L; Doorley L; Stamnes MA; Kelly SL; Rogers PD; Moye-Rowley WS; Krysan DJ
    mSphere; 2021 Dec; 6(6):e0083021. PubMed ID: 34935446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular mechanisms of azole resistance in Candida tropicalis isolates causing invasive candidiasis in China.
    Fan X; Xiao M; Zhang D; Huang JJ; Wang H; Hou X; Zhang L; Kong F; Chen SC; Tong ZH; Xu YC
    Clin Microbiol Infect; 2019 Jul; 25(7):885-891. PubMed ID: 30472420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.